Monogenic Diabetes
📧 Sign up to get email alerts when something new happens for Monogenic Diabetes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: China Monogenic Diabetes Registry
This clinical trial registry entry outlines the China Monogenic Diabetes Registry, which is currently recruiting participants with neonatal …
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE)
A University of Exeter-led clinical trial is recruiting participants to study beta cell disorders arising from rare genetic variants. The st…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Glucokinase Activator in Monogenic Diabetes [Phase 2]
A Phase 2 clinical trial evaluating a glucokinase activator for monogenic diabetes is listed as not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical testing of an oral hypoglycemic therapy in carriers of monogenic variants within the Joslin Medalist Study has …
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes [NA]
Investigators are evaluating a screening and molecular-diagnosis-based approach to individualized management of monogenic diabetes. The stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: China Diabetes Registry by Metabolic Management Center
This entry describes a China Diabetes Registry study organized by the Metabolic Management Center. It is currently recruiting and aims to co…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Incretin Regulation of Insulin Secretion in Monogenic Diabetes [Phase 1]
A Phase 1 clinical trial evaluating incretin regulation of insulin secretion in individuals with monogenic diabetes has completed.